Skip to main content

Market Overview

UPDATE: Goldman Sachs Upgrades Thermo Fisher Scientific as End Market Dynamics Improve


In a report published Thursday, Goldman Sachs analyst Isaac Ro upgraded the rating on Thermo Fisher Scientific (NYSE: TMO) from Neutral to Buy, and raised the price target from $114.00 to $153.00.

In the report, Goldman Sachs noted, “We upgrade shares of Thermo Fisher Scientific (TMO) to Buy from Neutral with 24% upside to our new $153 12-month price target. Although TMO shares have outperformed over the past 12 months (+4,500bps vs. S&P 500 and +3,100bps vs. XLV), we think consensus still underappreciates Thermo's long-term growth profile and potential for continued multiple expansion.”

Thermo Fisher Scientific closed on Wednesday at $121.81.

Latest Ratings for TMO

Mar 2021BarclaysInitiates Coverage OnOverweight
Feb 2021BTIGMaintainsBuy
Feb 2021CitigroupMaintainsBuy

View More Analyst Ratings for TMO
View the Latest Analyst Ratings


Related Articles (TMO)

View Comments and Join the Discussion!

Posted-In: Goldman Sachs Isaac RoAnalyst Color Upgrades Analyst Ratings

Latest Ratings

PBTruist SecuritiesMaintains88.0
CFRTruist SecuritiesMaintains111.0
FANGTruist SecuritiesMaintains105.0
SBNYCredit SuisseMaintains250.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at